FDA Announces Collection of Information for Review by Office of Management and Budget

Summary

The Food and Drug Administration (FDA) is submitting a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to obtain approval for the collection of data on nonprescription drug products.